申请人:SERRANO-WU Michael H.
公开号:US20150065517A1
公开(公告)日:2015-03-05
The present invention provides organic compounds of the following structure;
A-L1-B-C-D-L2-E
that are useful for treating or preventing conditions or disorders associated with DGAT1 activity in animals, particularly humans.
本发明提供了以下结构的有机化合物:A-L1-B-C-D-L2-E,它们对于治疗或预防与DGAT1活性有关的动物状况或疾病,特别是人类,非常有用。